Lung Neoplasms
"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
Descriptor ID |
D008175
|
MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 13 | 2 | 15 | 1995 | 12 | 3 | 15 | 1996 | 14 | 4 | 18 | 1997 | 22 | 2 | 24 | 1998 | 14 | 2 | 16 | 1999 | 12 | 1 | 13 | 2000 | 15 | 1 | 16 | 2001 | 9 | 7 | 16 | 2002 | 28 | 5 | 33 | 2003 | 19 | 3 | 22 | 2004 | 35 | 5 | 40 | 2005 | 40 | 4 | 44 | 2006 | 36 | 9 | 45 | 2007 | 38 | 6 | 44 | 2008 | 38 | 5 | 43 | 2009 | 40 | 4 | 44 | 2010 | 49 | 3 | 52 | 2011 | 41 | 6 | 47 | 2012 | 62 | 4 | 66 | 2013 | 64 | 11 | 75 | 2014 | 62 | 7 | 69 | 2015 | 61 | 8 | 69 | 2016 | 71 | 7 | 78 | 2017 | 70 | 6 | 76 | 2018 | 78 | 8 | 86 | 2019 | 73 | 5 | 78 | 2020 | 77 | 3 | 80 | 2021 | 68 | 3 | 71 | 2022 | 76 | 0 | 76 | 2023 | 52 | 0 | 52 | 2024 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Drilon A, Camidge DR, Lin JJ, Kim SW, Solomon BJ, Dziadziuszko R, Besse B, Goto K, de Langen AJ, Wolf J, Lee KH, Popat S, Springfeld C, Nagasaka M, Felip E, Yang N, Velcheti V, Lu S, Kao S, Dooms C, Krebs MG, Yao W, Beg MS, Hu X, Moro-Sibilot D, Cheema P, Stopatschinskaja S, Mehta M, Trone D, Graber A, Sims G, Yuan Y, Cho BC. Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer. N Engl J Med. 2024 Jan 11; 390(2):118-131.
-
Chen N, Tyler LC, Le AT, Welsh EA, Fang B, Elliott A, Davies KD, Danhorn T, Riely GJ, Ladanyi M, Haura EB, Doebele RC. MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling. Mol Cancer Ther. 2024 Jan 03; 23(1):92-105.
-
Stuart CM, Dyas AR, Bronsert MR, Velopulos CG, Randhawa SK, David EA, Mitchell JD, Meguid RA. The Effect of Social Vulnerability on Initial Stage and Treatment for Non-Small Cell Lung Cancer. Lung Cancer. 2024 Feb; 188:107452.
-
Takeda T, Sasaki T, Ichinose J, Inoue Y, Okamoto T, Mie T, Furukawa T, Kasuga A, Oba A, Matsuura Y, Nakao M, Ozaka M, Mun M, Takahashi Y, Sasahira N. Outcomes of lung oligometastasis in pancreatic cancer. Jpn J Clin Oncol. 2023 Dec 07; 53(12):1144-1152.
-
Jennings EM, Camidge DR, Gadgeel S, Barker S. Trial Design and Optimal Determination of CNS Activity of Small Molecule Targeted Therapy in NSCLC. Clin Lung Cancer. 2024 Mar; 25(2):91-99.
-
Blomberg R, Sompel K, Hauer C, Smith AJ, Pe?a B, Driscoll J, Hume PS, Merrick DT, Tennis MA, Magin CM. Hydrogel-Embedded Precision-Cut Lung Slices Model Lung Cancer Premalignancy Ex Vivo. Adv Healthc Mater. 2024 Feb; 13(4):e2302246.
-
Rodilla AM, Valanparambil RM, Mack PC, Hsu CY, Cagan J, Tavolacci SC, Carre?o JM, Brody R, Moore A, King JC, Gomez JE, Rohs N, Rolfo C, Bunn PA, Gerber DE, Minna JD, Krammer F, Ramalingam SS, Garc?a-Sastre A, Shyr Y, Ahmed R, Hirsch FR. Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer. Cancer Cell. 2023 11 13; 41(11):1838-1840.
-
Liao Y, Remsing Rix LL, Li X, Fang B, Izumi V, Welsh EA, Monastyrskyi A, Haura EB, Koomen JM, Doebele RC, Rix U. Differential network analysis of ROS1 inhibitors reveals lorlatinib polypharmacology through co-targeting PYK2. Cell Chem Biol. 2024 Feb 15; 31(2):284-297.e10.
-
Escalon JG, Podolanczuk AJ, Aronson KI, Legasto AC, Gruden JF, Lynch DA, Rachid L, Rabkova Y, Steinberger S. Practice patterns in reporting interstitial lung abnormality at a tertiary academic medical center. Clin Imaging. 2023 Dec; 104:109996.
-
Jurica JM, Carsten B, Balakhani S, Haag MM, Aisner DL, Camidge DR. CSF Cytology Identifies Mechanisms of Tyrosine Kinase Inhibitor Resistance in Patient With EGFR-Mutated NSCLC With CNS Progression. Clin Lung Cancer. 2024 Jan; 25(1):77-79.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|